Cytokine-Induced Transcription in Depressed Inpatients Undergoing Psychotherapy
CitDip
1 other identifier
observational
63
0 countries
N/A
Brief Summary
The goal of this observational study is to measure the levels of cytokine-induced transcription factor activation in a cohort of depressed inpatients undergoing psychotherapy. The study aims to answer the following main questions:
- Do psychological traits (i.e.: social inhibition, negative affectivity, ...) affect the activation of immunomodulatory transcription factors (STAT3, NFkB) in depressed patients?
- Are subjects with these psychological traits affected differently by psychotherapeutic intervention? Study subjects are assessed for their psychological and behavioral traits and receive psychotherapeutic care over several weeks during hospital treatment. Peripheral blood mononuclear cells are isolated from the study subjects, and activation of transcription factors is measured by flow cytometry.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2017
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 9, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
April 23, 2024
CompletedFirst Posted
Study publicly available on registry
April 29, 2024
CompletedApril 30, 2024
April 1, 2024
5.2 years
April 23, 2024
April 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Change in depression
Hospital Depression and Anxiety Scale (HADS). The HADS instrument is a 14-item scale, with seven items relating to anxiety and seven relating to depression item. Each item on qestionnaire is scored from 0-3 resulting in a score between 0 and 21 for either anxiety or depression with higher scores meaning a worse outcome.
6 weeks
Interventions
Subject receive psychotherapy during hospital treatment.
Eligibility Criteria
Depressed inpatients, admitted for multimodal treatment, including psychotherapy.
You may qualify if:
- Diagnosis of current depression
You may not qualify if:
- inadequate knowledge of the German language
- unable to give informed consent
- severe psychiatric comorbidities, such as drug abuse and psychotic diseases
- deemed critically unstable by their treating physician
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor, Head of the Molecular Psychocardiology laboratory
Study Record Dates
First Submitted
April 23, 2024
First Posted
April 29, 2024
Study Start
January 1, 2017
Primary Completion
March 9, 2022
Study Completion
January 1, 2024
Last Updated
April 30, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share